内容へ

輸血の代替療法の費用対効果

整形外科

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (新しいタブで開く)

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP.

出典‎: J Bone Joint Surg Am 2013;95(21):1969-74.

インデックス‎: PubMed 24196467

DOI‎: 10.2106/JBJS.L.00908

https://www.ncbi.nlm.nih.gov/pubmed/24196467 (新しいタブで開く)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (新しいタブで開く)

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP.

出典‎: J Bone Joint Surg Am 2013;95(21):1961-8.

インデックス‎: PubMed 24196466

DOI‎: 10.2106/JBJS.L.00907

https://www.ncbi.nlm.nih.gov/pubmed/24196466 (新しいタブで開く)

Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (新しいタブで開く)

Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, Freedman J, Waters JH, Farmer S, Leahy MF, Zacharowski K, Meybohm P, Choorapoikayil S

出典‎: Ann Surg 2019;269(5):794-804.

インデックス‎: PubMed 30418206

DOI‎: 10.1097/SLA.0000000000003095

https://www.ncbi.nlm.nih.gov/pubmed/30418206 (新しいタブで開く)

Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (新しいタブで開く)

Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM.

出典‎: Spine 2009;34(19):2096-103.

インデックス‎: PubMed 19730217

DOI‎: 10.1097/BRS.0b013e3181b1fab2

https://www.ncbi.nlm.nih.gov/pubmed/19730217 (新しいタブで開く)

The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (新しいタブで開く)

Cankaya D, Dasar U, Satilmis AB, Basaran SH, Akkaya M, Bozkurt M.

出典‎: J Orthop Surg 2017;25(1):2309499016684725.

インデックス‎: PubMed 28176599

DOI‎: 10.1177/2309499016684725

https://www.ncbi.nlm.nih.gov/pubmed/28176599 (新しいタブで開く)

An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (新しいタブで開く)

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

出典‎: J Arthroplasty 2013;28(8 Suppl):74-7.

インデックス‎: PubMed 24034510

DOI‎: 10.1016/j.arth.2013.06.037

https://www.ncbi.nlm.nih.gov/pubmed/24034510 (新しいタブで開く)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (新しいタブで開く)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

出典‎: J Bone Joint Surg Am 2012;94(21):1952-8.

インデックス‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (新しいタブで開く)

Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (新しいタブで開く)

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ.

出典‎: J Knee Surg 2017;30(5):460-6.

インデックス‎: PubMed 27699724

DOI‎: 10.1055/s-0036-1593362

https://www.ncbi.nlm.nih.gov/pubmed/27699724 (新しいタブで開く)

Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (新しいタブで開く)

Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr.

出典‎: J Arthroplasty 2017;32(8):2375-80.

インデックス‎: PubMed 28343823

DOI‎: 10.1016/j.arth.2017.02.068

https://www.ncbi.nlm.nih.gov/pubmed/28343823 (新しいタブで開く)

Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. (新しいタブで開く)

Dobosz B, Dutka J, Dutka L, Maleta P.

出典‎: Ortop Traumatol Rehabil 2012;14(5):421-8.

インデックス‎: PubMed 23208933

DOI‎: 10.5604/15093492.1016367

https://www.ncbi.nlm.nih.gov/pubmed/23208933 (新しいタブで開く)

The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (新しいタブで開く)

Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, Verma R, Mohammad S, Siddique I.

出典‎: Spine J 2017;17(7):977-82.

インデックス‎: PubMed 28323241

DOI‎: 10.1016/j.spinee.2017.03.004

https://www.ncbi.nlm.nih.gov/pubmed/28323241 (新しいタブで開く)

Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (新しいタブで開く)

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

出典‎: Orthop Clin North Am 2017;48(2):109-15.

インデックス‎: PubMed 28336035

DOI‎: 10.1016/j.ocl.2016.12.001

https://www.ncbi.nlm.nih.gov/pubmed/28336035 (新しいタブで開く)

Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (新しいタブで開く)

Fenelon C, Galbraith JG, Kearsley R, Motherway C, Condon F, Lenehan B.

出典‎: Ir Med J 2018;111(4):730.

インデックス‎: PubMed 30465599

https://www.ncbi.nlm.nih.gov/pubmed/30465599 (新しいタブで開く)

Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (新しいタブで開く)

Frank SM, Pippa A, Sherd I, Scott AV, Lo BD, Cruz NC, Hendricks EA, Ness PM, Chaturvedi S, Resar LMS.

出典‎: Anesth Analg 2022;135(3):576-85.

インデックス‎: PubMed 35977366

DOI‎: 10.1213/ANE.0000000000006114

https://www.ncbi.nlm.nih.gov/pubmed/35977366 (新しいタブで開く)

Tranexamic acid decreases blood loss after total shoulder arthroplasty. (新しいタブで開く)

Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B.

出典‎: J Shoulder Elbow Surg 2016;25(4):614-8.

インデックス‎: PubMed 26652697

DOI‎: 10.1016/j.jse.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26652697 (新しいタブで開く)

Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (新しいタブで開く)

Fusaro MV, Nielsen ND, Nielsen A, Fontaine MJ, Hess JR, Reed RM, DeLisle S, Netzer G.

出典‎: Transfusion 2017;57(2):357-66.

インデックス‎: PubMed 28019009

DOI‎: 10.1111/trf.13936

https://www.ncbi.nlm.nih.gov/pubmed/28019009 (新しいタブで開く)

Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. (新しいタブで開く)

Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, Sierra RJ.

出典‎: J Arthroplasty 2013;28(8 Suppl):137-9.

インデックス‎: PubMed 23886409

DOI‎: 10.1016/j.arth.2013.04.054

https://www.ncbi.nlm.nih.gov/pubmed/23886409 (新しいタブで開く)

Cell saver for adult spinal deformity surgery reduces cost. (新しいタブで開く)

Gum JL, Carreon LY, Kelly MP, Hostin R, Robinson C, Burton DC, Polly DW, Shaffrey CI, LaFage V, Schwab FJ, Ames CP, Kim HJ, Smith JS, Bess RS; International Spine Study Group.

出典‎: Spine Deform 2017;5(4):272-6.

インデックス‎: PubMed 28622903

DOI‎: 10.1016/j.jspd.2017.01.005

https://www.ncbi.nlm.nih.gov/pubmed/28622903 (新しいタブで開く)

Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (新しいタブで開く)

Haase DR, Kimbrel B, Bombardier B, Templeton KJ, Rosenthal HG, Sweeney KR.

出典‎: J Am Acad Orthop Surg 2021;29(22):961-9.

インデックス‎: PubMed 34570739

DOI‎: 10.5435/JAAOS-D-20-00971

https://www.ncbi.nlm.nih.gov/pubmed/34570739 (新しいタブで開く)

Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (新しいタブで開く)

Harper RA, Sucher MG, Giordani M, Nedopil AJ.

出典‎: Orthopedics 2017;40(6):e1044-9.

インデックス‎: PubMed 28968480

DOI‎: 10.3928/01477447-20170925-07

https://www.ncbi.nlm.nih.gov/pubmed/28968480 (新しいタブで開く)

Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (新しいタブで開く)

Harris RN, Moskal JT, Capps SG.

出典‎: J Arthroplasty 2015;30(2):192-5.

インデックス‎: PubMed 25534861

DOI‎: 10.1016/j.arth.2014.08.020

https://www.ncbi.nlm.nih.gov/pubmed/25534861 (新しいタブで開く)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (新しいタブで開く)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

出典‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

インデックス‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (新しいタブで開く)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (新しいタブで開く)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

出典‎: Transfusion 2017;57(6):1347-58.

インデックス‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (新しいタブで開く)

Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. (新しいタブで開く)

Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D.

出典‎: Br J Anaesth 2007;99(6):794-800.

インデックス‎: PubMed 17928302

DOI‎: 10.1093/bja/aem266

https://www.ncbi.nlm.nih.gov/pubmed/17928302 (新しいタブで開く)

A safe, simple and cost-effective protocol for blood transfusion in primary total knee replacement. (新しいタブで開く)

Mehra A, Murray J, DeAlwis C.

出典‎: Ann R Coll Surg Engl 2004;86(4):260-2.

インデックス‎: PubMed 15239867

DOI‎: 10.1308/147870804551

https://www.ncbi.nlm.nih.gov/pubmed/15239867 (新しいタブで開く)

Are allogeneic transfusions decreasing in total knee arthroplasty patients? National Inpatient Sample 2009-2013. (新しいタブで開く)

Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, Delanois RE.

出典‎: J Arthroplasty 2018;33(6):1705-12.

インデックス‎: PubMed 29352682

DOI‎: 10.1016/j.arth.2017.12.014

https://www.ncbi.nlm.nih.gov/pubmed/29352682 (新しいタブで開く)

Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (新しいタブで開く)

Moskal JT, Harris RN, Capps SG.

出典‎: J Arthroplasty 2015;30(3):365-8.

インデックス‎: PubMed 25458093

DOI‎: 10.1016/j.arth.2014.10.008

https://www.ncbi.nlm.nih.gov/pubmed/25458093 (新しいタブで開く)

The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. (新しいタブで開く)

Muñoz M, Ariza D, Campos A, Martín-Montañez E, Pavía J.

出典‎: Blood Transfus 2013;11(2):260-71.

インデックス‎: PubMed 23149145

DOI‎: 10.2450/2012.0139-12

https://www.ncbi.nlm.nih.gov/pubmed/23149145 (新しいタブで開く)

Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (新しいタブで開く)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J.

出典‎: Blood Transfus 2014;12(1):40-9.

インデックス‎: PubMed 24120595

DOI‎: 10.2450/2013.0088-13

https://www.ncbi.nlm.nih.gov/pubmed/24120595 (新しいタブで開く)

Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty. (新しいタブで開く)

Ortega-Andreu M, Pérez-Chrzanowska H, Figueredo R, Gómez-Barrena E.

出典‎: Open Orthop J 2011;5:44-8.

インデックス‎: PubMed 21552468

DOI‎: 10.2174/1874325001105010044

https://www.ncbi.nlm.nih.gov/pubmed/21552468 (新しいタブで開く)

ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. (新しいタブで開く)

Pavenski K, Howell A, Mazer CD, Hare GMT, Freedman J.

出典‎: Anesth Analg 2022;135(3):448-58.

インデックス‎: PubMed 35977355

DOI‎: 10.1213/ANE.0000000000006065

https://www.ncbi.nlm.nih.gov/pubmed/35977355 (新しいタブで開く)

Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (新しいタブで開く)

Phan DL, Ani F, Schwarzkopf R.

出典‎: J Arthroplasty 2016;31(3):579-82.

インデックス‎: PubMed 26601635

DOI‎: 10.1016/j.arth.2015.10.001

https://www.ncbi.nlm.nih.gov/pubmed/26601635 (新しいタブで開く)

One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (新しいタブで開く)

Ralley FE, Berta D, Binns V, Howard J, Naudie DD.

出典‎: Clin Orthop Relat Res 2010;468(7):1905-11.

インデックス‎: PubMed 20063079

DOI‎: 10.1007/s11999-009-1217-8

https://www.ncbi.nlm.nih.gov/pubmed/20063079 (新しいタブで開く)

Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (新しいタブで開く)

Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti WE.

出典‎: J Arthroplasty 2018;33(7):2092-9.e9.

インデックス‎: PubMed 29605152

DOI‎: 10.1016/j.arth.2018.02.068

https://www.ncbi.nlm.nih.gov/pubmed/29605152 (新しいタブで開く)

Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. (新しいタブで開く)

Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG.

出典‎: Transfus Med 2009;19(4):202-6.

インデックス‎: PubMed 19706137

DOI‎: 10.1111/j.1365-3148.2009.00929.x

https://www.ncbi.nlm.nih.gov/pubmed/19706137 (新しいタブで開く)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (新しいタブで開く)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

出典‎: Int Orthop 2019;43(12):2707-14.

インデックス‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (新しいタブで開く)

Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. (新しいタブで開く)

Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M.

出典‎: J Orthop Surg Res 2011;6:22.

インデックス‎: PubMed 21600028

DOI‎: 10.1186/1749-799X-6-22

https://www.ncbi.nlm.nih.gov/pubmed/21600028 (新しいタブで開く)

Increased hospital costs associated with red blood cell transfusion. (新しいタブで開く)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

出典‎: Transfusion 2015;55(5):1082-9.

インデックス‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (新しいタブで開く)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (新しいタブで開く)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

出典‎: J Arthroplasty 2014;29(8):1512-5.

インデックス‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (新しいタブで開く)

Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (新しいタブで開く)

Wan S, Sparring V, Cabrales DA, Jansson KÅ, Wikman A.

出典‎: J Arthroplasty 2020;35(11):3084-8.

インデックス‎: PubMed 32654943

DOI‎: 10.1016/j.arth.2020.06.018

https://www.ncbi.nlm.nih.gov/pubmed/32654943 (新しいタブで開く)

Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. (新しいタブで開く)

Wu Y, Zeng Y, Hu Q, Li M, Bao X, Zhong J, Shen B.

出典‎: Thromb Res 2018;171:143-8.

インデックス‎: PubMed 30312799

DOI‎: 10.1016/j.thromres.2018.10.006

https://www.ncbi.nlm.nih.gov/pubmed/30312799 (新しいタブで開く)

Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. (新しいタブで開く)

Ye X, Lafuma A, Torreton E, Arnaud A.

出典‎: BMC Health Serv Res 2013;13:186.

インデックス‎: PubMed 23692862

DOI‎: 10.1186/1472-6963-13-186

https://www.ncbi.nlm.nih.gov/pubmed/23692862 (新しいタブで開く)

The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. (新しいタブで開く)

Zacharopoulos A, Apostolopoulos A, Kyriakidis A.

出典‎: Int Orthop 2007;31(3):303-8.

インデックス‎: PubMed 16810542

DOI‎: 10.1007/s00264-006-0173-0

https://www.ncbi.nlm.nih.gov/pubmed/16810542 (新しいタブで開く)